购物车
- 全部删除
- 您的购物车当前为空
Bragsin2 (6-methoxy-5-nitro-2-(trifluoromethyl)chromen-4-one) 是非竞争性的核苷酸交换因子 BRAG2选择性抑制剂,其 IC50值为 3 μM。它能够结合到 BRAG2 的 PH 结构域和磷脂双分子层的界面处,使 BRAG2 无法激活磷脂化的 Arf GTPase。它能够影响乳腺癌干细胞。
为众多的药物研发团队赋能,
让新药发现更简单!
Bragsin2 (6-methoxy-5-nitro-2-(trifluoromethyl)chromen-4-one) 是非竞争性的核苷酸交换因子 BRAG2选择性抑制剂,其 IC50值为 3 μM。它能够结合到 BRAG2 的 PH 结构域和磷脂双分子层的界面处,使 BRAG2 无法激活磷脂化的 Arf GTPase。它能够影响乳腺癌干细胞。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 289 | 现货 | |
5 mg | ¥ 678 | 现货 | |
10 mg | ¥ 1,080 | 现货 | |
25 mg | ¥ 2,170 | 现货 | |
50 mg | ¥ 3,480 | 现货 | |
100 mg | ¥ 4,970 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 748 | 现货 |
产品描述 | Bragsin2 (6-methoxy-5-nitro-2-(trifluoromethyl)chromen-4-one) is a hydration-resistant cell penetrant, selective and non-competitive inhibitor of Afr guanine nucleotide exchange factor BRAG2 that inhibits Arf GTPase activation, with an IC50 of 3 μM. Bragsin2 binds at the interface between the pleckstrin homology domain of BRAG2 and the lipid bilayer, leading BRAG2 unable to activate lipidated Arf GTPase. |
靶点活性 | BRAG2:3 μM |
体外活性 | Administration of 50?μM Bragsin2 inhibits Arf GTPase activation in HeLa cells[1]. Administration of 50?μM Bragsin2 inhibits the growth of breast cancer stem cells including SUM149 and S68, but has no effect on SUM159, which lacks adhesion molecules such as integrin and cadherin[1]. |
别名 | Bragsin 2, 6-methoxy-5-nitro-2-(trifluoromethyl)chromen-4-one |
分子量 | 289.16 |
分子式 | C11H6F3NO5 |
CAS No. | 342795-08-8 |
Smiles | COc1ccc2oc(cc(=O)c2c1[N+]([O-])=O)C(F)(F)F |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/ml (190.21 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容